| | | | |
![LOGO](https://capedge.com/proxy/CORRESP/0001193125-20-110913/g893414g07b80.jpg) | | New York Northern California Washington DC São Paulo London | | Paris Madrid Tokyo Beijing Hong Kong |
| | |
Davis Polk & Wardwell LLP 212 450 4000 tel 450 Lexington Avenue New York, NY 10017 | | | | |
April 17, 2020
Re: | The Charles Schwab Corporation |
| Registration Statement on FormS-4 |
Division of Corporation Finance
Office of Finance
U.S. Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549-3628
Dear Sir or Madam,
On behalf of our client, The Charles Schwab Corporation, a Delaware corporation (the “Company” or “Schwab”), we are responding to the comments from the Staff (the “Staff”) of the Securities and Exchange Commission (the “Commission”) relating to the Company’s Registration Statement on FormS-4 (the “Registration Statement”) contained in the Staff’s letter dated April 6, 2020 (the “Comment Letter”). In response to the comments set forth in the Comment Letter, the Company has revised the Registration Statement and is submitting Amendment No. 1 to the Registration Statement (“Amendment No. 1”) together with this response letter. Amendment No. 1 contains certain additional updates and revisions. We are also sending, under separate cover, a copy of Amendment No. 1 and marked copies of Amendment No. 1 showing the changes to the Registration Statement filed on March 10, 2020.
Set forth below are the Company’s responses to the Staff’s comments. For convenience, the Staff’s comments are repeated below in italics, followed by the Company’s response to the comments, as well as a summary of the responsive actions taken. We have included page numbers to refer to the location in Amendment No. 1 where the revised language addressing a particular comment appears.
The Company also wishes to advise the Staff that, consistent with our discussion with the Staff on April 6, 2020 and the Commission’s recent disclosure guidance, the Company intends to further revise the Registration Statement prior to effectiveness to provide additional disclosure on the risks ofCOVID-19 on the Company’s business, financial condition and results of operations. The Company is currently in the process of completing this analysis in connection with the Company’s business update and financial reporting. The Company expects to be in a position to include this additional disclosure in a subsequent amendment to the Registration Statement shortly after April 21, 2020.
The Company also wishes to supplementally advise the Staff that, as discussed with the Staff on April 6, 2020, the purchase price sensitivity analysis included in the pro forma financial statements on page 64 of Amendment No. 1 has been updated to reflect the closing price of Schwab common stock as of April 13, 2020, and the related disclosure has been revised to note the recent variance in the trading price of Schwab common stock.